Goodwin advised H.I.G. Capital on the deal. H.I.G. Capital, LLC announced that one of its affiliates acquired CLC Group Limited from its owner, the Armitage Family...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Travers Smith advised Abingworth on the deal, while Debevoise & Plimpton advised Carlyle. Abingworth announced its proposed acquisition by global investment firm Carlyle (NASDAQ:...
You must be a Standard 1 Year member to access this content.
Goodwin advised ReViral on the deal. Clifford Chance advised Pfizer. ReViral announced its acquisition by Pfizer. Pfizer will acquire ReViral for a total consideration of up to...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised EQT on the transaction while Goodwin represented ELEVATE. EQT executed the sale of its interest in ELEVATE, a leading provider of ESG and supply...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised CSafe Global on the deal. CSafe Global, a portfolio company of Frazier Healthcare Partners and Thomas H. Lee Partners, announced the completion of its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP, Khaitan & Co., Gitti and Partners, RDJ and Kinstellar have advised GTT Communications on the deal. Linklaters acted as legal advisor to I...
You must be a Standard 1 Year member to access this content.
